Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory
Investor's Business DailyNovartis stock tumbled Thursday after the firm dropped out of a key cancer treatment race vs. big players Amgen and Bristol Myers Squibb.
The post Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory appeared first on Investor…